The development and maintenance of Th1 and Th17 cells induced by TLR2 agonists should be evaluated as a mechanism to control cryptococcosis, although the immunomodulatory activity of TLR2 agonists in macrophages could be more relevant in combating cryptococcosis. The gene discussed is TLR2; the disease is cryptococcosis.